About LifeMD, Inc.
https://www.lifemd.comLifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States.
CEO
Justin Schreiber
Compensation Summary
(Year 2024)
Salary $311,250
Bonus $102,000
Stock Awards $260,000
Incentive Plan Pay $378,000
All Other Compensation $12,209
Total Compensation $1,063,459
Industry Medical - Pharmaceuticals
Sector Healthcare
Went public October 5, 2021
Method of going public Reg A+
Full time employees 304
Ratings Snapshot
Rating : D+
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 1
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0
Market Cap $980.84 M
52w High $27.44
52w Low $18.50
P/E -9.86
Volume 782
Outstanding Shares 43.98M
About LifeMD, Inc.
https://www.lifemd.comLifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $60.17M ▼ | $54.73M ▼ | $-3.81M ▼ | -6.33% ▼ | $-0.1 ▼ | $-133.33K ▼ |
| Q2-2025 | $62.22M ▼ | $55.69M ▲ | $-2.07M ▼ | -3.33% ▼ | $-0.06 ▼ | $1.92M ▼ |
| Q1-2025 | $65.7M ▲ | $54.51M ▲ | $1.38M ▲ | 2.11% ▲ | $0.01 ▲ | $5.2M ▲ |
| Q4-2024 | $64.25M ▲ | $53.81M ▲ | $-106.27K ▲ | -0.17% ▲ | $-0.02 ▲ | $3.57M ▲ |
| Q3-2024 | $53.27M | $52.26M | $-4.66M | -8.74% | $-0.14 | $-1.44M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $23.79M ▼ | $65.98M ▼ | $62.62M ▼ | $1.31M ▲ |
| Q2-2025 | $36.23M ▲ | $73.56M ▼ | $73.18M ▼ | $-1.78M ▲ |
| Q1-2025 | $34.39M ▼ | $73.61M ▲ | $74.01M ▼ | $-2.33M ▲ |
| Q4-2024 | $35M ▼ | $72.46M ▼ | $76.51M ▼ | $-5.49M ▲ |
| Q3-2024 | $37.59M | $72.56M | $78.51M | $-7.72M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-4.67M ▼ | $-147.14K ▼ | $-3.59M ▲ | $-8.7M ▼ | $-12.44M ▼ | $6.42M ▼ |
| Q2-2025 | $-1.57M ▼ | $8.64M ▲ | $-3.7M ▼ | $-3.1M ▼ | $1.83M ▲ | $11.51M ▲ |
| Q1-2025 | $1.92M ▲ | $3.07M ▲ | $-2.87M ▼ | $-812.56K ▲ | $-611.51K ▲ | $201.05K ▲ |
| Q4-2024 | $234.69K ▲ | $1.57M ▼ | $-2.72M ▲ | $-1.43M ▼ | $-2.58M ▼ | $-1.15M ▼ |
| Q3-2024 | $-5.48M | $6.2M | $-3.49M | $-825.58K | $1.88M | $2.71M |
Revenue by Products
| Product | Q3-2021 | Q1-2022 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Product and Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Cost Of Work Simpli Revenue | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Justin Schreiber
Compensation Summary
(Year 2024)
Salary $311,250
Bonus $102,000
Stock Awards $260,000
Incentive Plan Pay $378,000
All Other Compensation $12,209
Total Compensation $1,063,459
Industry Medical - Pharmaceuticals
Sector Healthcare
Went public October 5, 2021
Method of going public Reg A+
Full time employees 304
Ratings Snapshot
Rating : D+
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 1
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0